Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Key words. Pycnogenol; nuclear factor kappa B; adhesion molecule; antioxidant; human umbilical vein endothelial cell.  (1)
  • 1
    ISSN: 1420-9071
    Keywords: Key words. Pycnogenol; nuclear factor kappa B; adhesion molecule; antioxidant; human umbilical vein endothelial cell.
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology , Medicine
    Notes: Abstract. The transcriptional regulatory protein nuclear factor kappa B (NF-κB) participates in the control of gene expression of many modulators of inflammatory and immune responses, including vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1). The heightened expression of these adhesion molecules has been reported to play a critical role in atherosclerosis, inflammation, ischemic vascular disorders, diabetes, and cancer metastasis. In the present study, we investigated the effect of pycnogenol, an antioxidant phytochemical, on the activation of NF-κB and the induction of VCAM-1 and ICAM-1 in tumor necrosis factor (TNF)-α-treated human umbilical vein endothelial cells (HUVECs). Gel-shift analysis of HUVEC demonstrated that pretreatment with pycnogenol exhibited a concentration-dependent suppression of TNF-α-induced activation of NF-κB. Induction of VCAM-1 and ICAM-1 surface expression by TNF-α was dose-dependently reduced by pycnogenol. TNF-α significantly increased the release of superoxide anion and hydrogen peroxide from HUVECs. Pycnogenol dose-dependently inhibited their release. The ability of pycnogenol to inhibit NF-κB activation and VCAM-1 and ICAM-1 expression suggests that this phytochemical may play an important role in halting or preventing the atherogenic process.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...